𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of major histocompatibility complex class II antigens and interleukin-1 by epithelial cells of Warthin's tumor

✍ Scribed by Yuzo Ogawa; Sung-Soo Hong; Satoru Toyosawa; Chee-Keong Chang; Toshio Yagi


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
923 KB
Volume
66
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Polarized expression of major histocompa
✍ Marion A. Van Eijkeren; Peter J. Peters; Hans J. Geuze πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 458 KB

Polarized expression of major histocompatibility complex class I molecules in human endometrial Department of Obstetrics and and endocervical epithelial cells Gynaecologyn and Laboratory of ## Utrecht, Utrecht The localization of major histocompatibility complex (MHC) class I molecules in human

The overlooked β€œnonclassical” functions
✍ Maresa Altomonte; Carlo Pucillo; Michele Maio πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 159 KB πŸ‘ 2 views

Besides their "classical" antigenic peptide-presenting activity, major histocompatibility complex (MHC) class II antigens can activate different cellular functions in immune and nonimmune cells. However, this "nonclassical" role and its functional consequences are still substantially overlooked. In

Significance of the expression of major
✍ Young Suk Jo; Jun Chul Lee; Shengjin Li; Yun-Sun Choi; Youn-Sun Bai; Yun-Jeung K πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 231 KB

## Abstract Normal thyroid epithelial cells lack major histocompatibility complex (MHC) Class II antigen. Oncogenic kinases involved in papillary thyroid carcinoma (PTC) trigger the expression of Class II transactivator and MHC Class II complex. However, the relationship between MHC Class II antige

The effect of photodynamic therapy on tu
✍ Alan Belicha-Villanueva; Jonah Riddell; Naveen Bangia; Sandra O. Gollnick πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 299 KB

## Abstract ## Background and Objective Photodynamic therapy (PDT) is FDA‐approved anti‐cancer modality for elimination of early disease and palliation in advanced disease. PDT efficacy depends in part on elicitation of a tumor‐specific immune response that is dependent on cytotoxic T lymphocytes